Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production

Journal of Cellular Physiology

Volumn 211, Issue 2, 2007, Pages 448-456

  Catalano, Stefania ^a   Rizza, Pietro ^a   Gu, Owei ^a   Barone, Ines ^a   Giordano, Cinzia ^a   Marsico, Stefania ^a   Casaburi, Ivan ^a   Middea, Emilia ^a   Lanzino, Marilena ^a   Pellegrino, Michele ^a   Andò, Sebastiano ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AROMATASE; BUCLADESINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FAS LIGAND; FOLLITROPIN; MESSENGER RNA; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ESTROGEN ACTIVITY; ESTROGEN SYNTHESIS; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SERTOLI CELL;

ANDROSTENEDIONE; ANIMALS; AROMATASE; AROMATASE INHIBITORS; BUCLADESINE; CHROMATIN IMMUNOPRECIPITATION; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FAS LIGAND PROTEIN; FOLLICLE STIMULATING HORMONE; GENES, REPORTER; HELA CELLS; HUMANS; IMMUNE TOLERANCE; LUCIFERASES; MALE; MICE; MICE, INBRED BALB C; MUTATION; NITRILES; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SERTOLI CELLS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION; TRIAZOLES; UP-REGULATION;

EID: 34147217714     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20952     Document Type: Article

References (52)

1. Andrews NC, Faller DV. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
2. Andò S, Sirianni R, Forastieri P, Casaburi I, Lanzino M, Rago V, Giordano F, Giordano C, Carpino A, Pezzi V. 2001. Aromatase expression in prepubertal Sertoli cells: Effect of thyroid hormone. Mol Cell Endocrinol 178:11-21.
3. Armstrong DT, Dorrington JH. 1977. Estrogen biosynthesis in ovaries and testes. Adv Sex Horm Res 32:17-258.
4. Bart J, Green HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaanburg W, Sleijfer DT, de Vries EG. 2002. An oncological view on the blood-testis barrier. Lancet Oncol 3:357-363.
5. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630-632.
6. Bradford MM. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Carreau S, Lambard S, Delalande C, Denis-Galeraud I, Bilinska B, Bourguiba S. 2003. Aromatase expression and role of estrogens in male gonad: A review. Reprod Biol Endocrinol 1:35.
8. Catalano S, Pezzi V, Chimento A, Giordano C, Carpino A, Young M, McPhaul MJ, Andò S. 2003. Triiodothyronine decreases the activity of the proximal promoter (PII) of the Aromatase gene in the mouse Sertoli cell line TM4. Mol Endocrinol 17:923-934.
9. Cowley SM, Hoare S, Mosselman S, Parker MG. 1997. Estrogen receptor alpha and beta form heterodimers on DNA. J Biol Chem 272:19858-19862.
10. D'Abrizio P, Baldini E, Russo PF, Biordi L, Graziano FM, Rucci N, Properzi G, Francavilla S, Ulisse S. 2004. Ontogenesis and cell specific localizzation of Fas ligand expression in the rat testis. Int J Androl 27:304-310.
11. De Cesaris P, Filippini A, Cervelli C, Riccioli A, Muci S, Storace G, Stefanini M, Riparo E. 1992. Immunosuppressive molecules produced by Sertoli cells cultured in vitro: Biological effects on lymphocytes. Biochem Biophys Res Commun 186:1639-1646.
12. Dorrington JH, Armstrong DT. 1975. Follicle-stimulating hormone stimulates estradiol-17β synthesis in cultured Sertoli cells. Cell Biol 72:2677-2681.
13. Ferguson TA, Griffith TS. 1997. A vision of cell death: Insight into immune privilege. Immunol Rey 156:167-184.
14. Ferguson TA, Green DR, Griffith TS. 2002. Cell death and immune privilege. Int Rev Immunol 21:153-172.
15. Filippini A, Riccioli A, Padula F, Lauretti P, D'Alessio A, De Cesaris P, Gandini L, Lenzi A, Riparo E. 2001. Control and impairment of immune privilege in the testis and semen. Human Reprod Update 7:444-449.
16. Francavilla S, D'Abrizio P, Rucci N, Silvano G, Properzi G, Straface E, Cordeschi G, Necozione S, Gnessi L, Arizzi M, Ulisse S. 2000. Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis. J Clin Endocrinol Metab 85:2692-2700.
17. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Muller C, Tschopp J. 1996. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 133:335-343.
18. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Nature 270:1189-1192.
19. Griswold MD. 1998. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol 9:411-416.
20. Griswold MD, Morales C, Sylvester SR. 1988. Molecular biology of the Sertoli cell. Oxf Rev Reprod Biol 10:124-161.
21. Guller S. 1997. Role of Fas ligand in conferring immune privilege to non-lymphoid cells. Ann NY Acad Sci 828:268-272.
22. Kasihatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. 1998. DNA damaging agents induce expression of Fas lignd and subsequent apoptosis in T lynphocytes via the actiation of NF-kB and AP-1. Mol Cell 1:543-551.
23. Kavurma MM, Khachigian LM. 2003. Signaling and transcriptional control of FasL gene expression. Cell Death Differ 10:36-44.
24. Kavurma MM, Santiago FS, Bonfoco E, Khachigian LM. 2001. Sp-1 phosphorylation regulates apoptosis via extracellular FasL-Fas engagement. J Biol Chem 276:4964-4971.
25. Kirschhoff S, Sebens T, Baumann S, Krueger A, Zawatzky R, Li-Webber M, Meini E, Neipel F, Fieckenstein B, Krammer PH. 2002. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J Immunol 168:1226-1234.
26. Krishnan V, Wang X, Safe S. 1994. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269:15912-15917.
27. Latinis KM, Norian LA, Eliason SL, Koretzky GA. 1997. Two NFAT transcription factor binding sites partecipate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem 272:31427-31434.
28. Lee J, Richburg JH, Younkin SC, Boekelheide K. 1997. The Fas system is a key regulator of germ cell apoptosis in testis. Endocrinology 138:2081-2088.
29. Levallet J, Bilinska B, Mittre H, Genissel C, Fresnel J, Carreau S. 1998. Expression and immunolocalization of functional cytochrome P450 aromatase in mature rat tesicular cells. Biol Reprod 58:919-926.
30. Lynch DH, Ramsdell F, Alderson MR. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569-574.
31. Mather J. 1980. Establishment and characterization of two distinct mouse testicular epithelial cell lines. Biol Reprod 23:243-252.
32. Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST. 1998. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: Funcional anlaysis in T cell hybridoma. J Immunol 161:3469-3473.
33. McClure RF, Heppelmann CJ, Paya CV. 1999. Constitutive Fas ligand gene transcription in Sertoli cells is regulated by Sp1. J Biol Chem 274:7756-7762.
34. Mittelstadt PR, Ashwell JD. 1998. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol Cell Biol 18:3744-3751.
35. Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, Muzaffar S, Kohen F. 2003. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol 170:114-122.
36. Nagata S, Goldstein P. 1995. The Fas death factor. Science 267:1449-1456.
37. Porter W, Saville B, Holvik D, Safe S. 1997. Funcional synergy between the transcription factor Sp-1 and the estrogen receptor. Mol Endocrinol 11:1569-1580.
38. Qin C, Singh P, Safe S. 1998. Transcriptional activation of insulin-like growth factor binding protein 4 by 17β-estradiol in MCF-7 cells: Role of estrogen receptor-Sp1 complexes. Endocrinology 140:2501-2508.
39. Saas P, Walker P, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Meir EGV, deTribolet N, Tschopp J, Dietrich PY. 1997. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain? J Clin Invest 99:1173-1178.
40. Sanberg PR, Borlongan CV, Saporta S, Cameron DF. 1996. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat Biotechnol 114:1692-1695.
41. Sapi E, Brown WD, Aschkenazi S, Lim C, Munoz A, Kacinski BM, Rutherford T, Mor G. 2002. Regulation of Fas ligand expression by estrogen in normal ovary. J Soc Gynecol Investig 9:243-250.
42. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson JA, Safe S. 2000. Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp-1) promoter elements. J Biol Chem 275:5379-5387.
43. Selam B, Kayisli UA, Mulayim N, Arici A. 2001. Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol Reprod 65:979-985.
44. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown H. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
45. Sharpe RM, McKinnell C, Kivlin C, Fisher JS. 2003. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125:769-784.
46. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amameh B, Ito Y, Fisher CR, Mandelson CR, Bulun SE. 1994. Aromatase cytocrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15:342-355.
47. Suda T, Takahashi T, Goldstein P, Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
48. Sun G, Porter W, Safe S. 1998. Estrogen-induced retinoic acid receptor α1 gene expression: Role of estrogen receptor-Sp1 complex. Mol Endocrinol 12:882-890.
49. Tora L, Mullick A, Metger D, Ponglikitmongkol M, Park I, Chambon P. 1989. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 88:1981-1986.
50. Uckman D, Steele A, Cherry Wang BY, Chamizo W, Koutsonikolis A, Gilbert-Barness E, Good RA. 1997. Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 3:655-662.
51. Van der Molen HJ, Brinkmann AO, De Jong FH, Rommeerts FF. 1981. Testicular oestrogens. J Endocrinol 89:33P-46P.
52. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274-1279.